Net earnings excluding special items came in at $34.6 million, while diluted earnings per share (EPS) on this basis were $0.15, up $0.07 from the same quarter the previous year.
This exceeds the $0.07 to $0.10 range the company provided in November. The analyst consensus estimate was $0.09.
Reflecting special items, net earnings and diluted EPS on a generally accepted accounting practice basis were $12.1 million and $0.05, respectively.
This is a significant improvement on the year-earlier net loss of $94.5 million and loss per share of $0.39.
"The IT spending environment remains challenging, but the third quarter was a good one for BMC as we exceeded our EPS estimate, grew total revenues and licence revenues and completed our acquisition of Remedy," says Rob Clarkson, country manager, BMC SA.
"Our Patrol business showed major improvement, and there was rapid take-up of Patrol Express, our new agentless monitoring solution."
Total revenue in the third quarter was $349.6 million, an increase of 9% over the year-earlier quarter.
Total licence revenue increased 11% to $168.5 million and maintenance revenue increased 9% to $159.1 million.
Total Remedy results, included in BMC`s third-quarter results, reflected revenue of $25 million and expenses of $15.3 million, excluding amortisation of intangibles, for the six-week post-acquisition period from 21 November.
Cash flow from operations in the quarter was $48 million. Cash and marketable securities at the end of the quarter were $900 million. The company continues to have no debt.
Related stories:
BMC, MGX to benefit from Remedy acquisition
Share